Goldblum A - Search Results

1

Human-Based Immune Responsive In Vitro Infection Models for Validation of Novel TLR4 Antagonists Identified by Computational Discovery.

Merk H, Amran-Gealia T, Finkelmeier D, Kohl C, Pichota I, Stern N, Rupp S, Goldblum A, Burger-Kentischer A. Merk H, et al. Among authors: goldblum a. Microorganisms. 2022 Jan 22;10(2):243. doi: 10.3390/microorganisms10020243. Microorganisms. 2022. PMID: 35208698 Free PMC article.

2

Computational Discovery and Experimental Confirmation of TLR9 Receptor Antagonist Leads.

Zatsepin M, Mattes A, Rupp S, Finkelmeier D, Basu A, Burger-Kentischer A, Goldblum A. Zatsepin M, et al. Among authors: goldblum a. J Chem Inf Model. 2016 Sep 26;56(9):1835-46. doi: 10.1021/acs.jcim.6b00070. Epub 2016 Sep 1. J Chem Inf Model. 2016. PMID: 27537371

3

Dual Inhibitors of AChE and BACE-1 for Reducing Aβ in Alzheimer's Disease: From In Silico to In Vivo.

Stern N, Gacs A, Tátrai E, Flachner B, Hajdú I, Dobi K, Bágyi I, Dormán G, Lőrincz Z, Cseh S, Kígyós A, Tóvári J, Goldblum A. Stern N, et al. Among authors: goldblum a. Int J Mol Sci. 2022 Oct 28;23(21):13098. doi: 10.3390/ijms232113098. Int J Mol Sci. 2022. PMID: 36361906 Free PMC article.

4

Candidate Therapeutics by Screening for Multitargeting Ligands: Combining the CB2 Receptor With CB1, PPARγ and 5-HT4 Receptors.

El-Atawneh S, Goldblum A. El-Atawneh S, et al. Among authors: goldblum a. Front Pharmacol. 2022 Feb 28;13:812745. doi: 10.3389/fphar.2022.812745. eCollection 2022. Front Pharmacol. 2022. PMID: 35295337 Free PMC article.

5

Computational design of substrate selective inhibition.

Da'adoosh B, Kaito K, Miyashita K, Sakaguchi M, Goldblum A. Da'adoosh B, et al. Among authors: goldblum a. PLoS Comput Biol. 2020 Mar 20;16(3):e1007713. doi: 10.1371/journal.pcbi.1007713. eCollection 2020 Mar. PLoS Comput Biol. 2020. PMID: 32196495 Free PMC article.

6

Activity Models of Key GPCR Families in the Central Nervous System: A Tool for Many Purposes.

El-Atawneh S, Goldblum A. El-Atawneh S, et al. Among authors: goldblum a. J Chem Inf Model. 2023 Jun 12;63(11):3248-3262. doi: 10.1021/acs.jcim.2c01531. Epub 2023 May 31. J Chem Inf Model. 2023. PMID: 37257045 Free PMC article.

7

Predicting oral druglikeness by iterative stochastic elimination.

Rayan A, Marcus D, Goldblum A. Rayan A, et al. Among authors: goldblum a. J Chem Inf Model. 2010 Mar 22;50(3):437-45. doi: 10.1021/ci9004354. J Chem Inf Model. 2010. PMID: 20170135

8

Structural basis of glycogen branching enzyme deficiency and pharmacologic rescue by rational peptide design.

Froese DS, Michaeli A, McCorvie TJ, Krojer T, Sasi M, Melaev E, Goldblum A, Zatsepin M, Lossos A, Álvarez R, Escribá PV, Minassian BA, von Delft F, Kakhlon O, Yue WW. Froese DS, et al. Among authors: goldblum a. Hum Mol Genet. 2015 Oct 15;24(20):5667-76. doi: 10.1093/hmg/ddv280. Epub 2015 Jul 21. Hum Mol Genet. 2015. PMID: 26199317 Free PMC article.

9

Discovering Novel and Diverse Iron-Chelators in Silico.

Basu A, Sohn YS, Alyan M, Nechushtai R, Domb AJ, Goldblum A. Basu A, et al. Among authors: goldblum a. J Chem Inf Model. 2016 Dec 27;56(12):2476-2485. doi: 10.1021/acs.jcim.6b00450. Epub 2016 Dec 1. J Chem Inf Model. 2016. PMID: 28024407

10

Prediction and Experimental Confirmation of Novel Peripheral Cannabinoid-1 Receptor Antagonists.

El-Atawneh S, Hirsch S, Hadar R, Tam J, Goldblum A. El-Atawneh S, et al. Among authors: goldblum a. J Chem Inf Model. 2019 Sep 23;59(9):3996-4006. doi: 10.1021/acs.jcim.9b00577. Epub 2019 Sep 4. J Chem Inf Model. 2019. PMID: 31433190

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

65 results

Search Page